Status:

COMPLETED

BEATS 2: Music Therapy in Sickle Cell

Lead Sponsor:

University Hospitals Cleveland Medical Center

Collaborating Sponsors:

Kulas Foundation

Conditions:

Sickle Cell Disease

Eligibility:

All Genders

18-35 years

Phase:

NA

Brief Summary

The purpose of this study is to investigate the effects of the BEATS music therapy program on the self-efficacy, trust, knowledge, and adherence of young adult patients with SCD. Primary Hypotheses: ...

Eligibility Criteria

Inclusion

  • Subject is between 18 and 35 years of age
  • Subject is diagnosed with sickle cell disease
  • Subject is able to speak and understand English
  • Subject has a working email address.
  • Subject has access to a mobile device with email capabilities.

Exclusion

  • Subject has significant hearing impairment that has not been corrected
  • Subject has significant visual impairment that has not been corrected

Key Trial Info

Start Date :

June 26 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2018

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03233269

Start Date

June 26 2017

End Date

September 30 2018

Last Update

October 22 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals Seidman Cancer Center

Cleveland, Ohio, United States, 44106

BEATS 2: Music Therapy in Sickle Cell | DecenTrialz